Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Bristol-Myers Squibb has said it will buy biotech MyoKardia in a $13.1 billion takeover that marks a step up in its development of cardiovascular drugs. The all-cash deal is mainly about MyoKardia’s ...
To start this Node.js microservice run node app/server.js. To use the API first load the concept JSON object from Snowstorm using GET /browser/{branch}/concepts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback